Johnson & Johnson and Proctor & Gamble Companies

Johnson & Johnson Companies Biotech, one of the Johnson & Johnson Companies, has been very concerned with the FDA. The FDA has started to halt very strict on what drugs they let in the interchange; since, the incidents with other well known drugs such as Phen-fen and Lotronex were pulled from the securities manufacturing for safety concerns. They have started to get gun-shy with putting other drugs on the market. The FDA will be a big future reward exception for the medical companies incorporated with Johnson & Johnson Companies. Biotech suffered when the FDA made them do more clinical studies on the solelyergy drug, Soltara, which was their biggest drug to come expose this year. Studies recognized that a condition called QT Prolongation, which can guide on teacher to irregular heart beat, is common in antihistamines. In departed studies that were done, they discovered that 2 of the 3 concerns from the FDA were present, but at that place were no signs of QT prolongation. Johnson & Johnson (JNJ.N) and its smaller partner Alkermes Inc. (ALKS.O) said in earlyish July the FDA rejected their request to market an inject capable meter reading of J&Js lucrative schizophrenia treatment Risperdal, send Alkermes stock plunging 68 percent.

An analyst opus at the cartridge holder cited an increased risk of crabby person found in scrutiny of the drug in rodents -- flat though the drug survived triplet phases of clinical trials in public without raising a of import cancer concern. This was a major set back for the caller-up as well as a future challenge. It may be years forward th ey can finish all of the studies and put the! drug on the market. The FDA has even requested drugs be tested that have been soundly tested already, if they are in any category that has experienced problems. This creates money problems in most... If you need to get a upright essay, order it on our website: BestEssayCheap.com

If you want to get a full essay, visit our page: cheap essay